As of Sep 20
| +0.40 / +2.70%|
The 9 analysts offering 12-month price forecasts for Heron Therapeutics Inc have a median target of 28.00, with a high estimate of 42.00 and a low estimate of 26.00. The median estimate represents a +84.21% increase from the last price of 15.20.
The current consensus among 9 polled investment analysts is to Buy stock in Heron Therapeutics Inc. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.